Reading Time: < 1 minute

Financial
-Several major banks, including BoC, CCB, and CMB, have successively launched pure credit business loan products with annual interest rates of around 3%, much lower vs previous level, Yicai reported.

Sector News
-The MIIT convened the 15th Manufacturing Enterprises Symposium, emphasizing the need to regulate low-priced and disorderly competition in the PV industry in accordance with laws and regulations, guide enterprises to improve product quality, and promote the orderly exit of outdated production capacity.
-The National Medical Products Administration issued an announcement on measures to optimize lifecycle regulation and support the innovative development of high-end medical devices. It mentioned to introduce supportive policies for medical device products based on brain-computer interface technology.

Data
-CPCA: retail sales of China’s passenger vehicles and NEVs rise 15%/25% yoy in June, up 5%/4% mom respectively.

July 3 Block Trade Info
*Discount
-ArcSoft (688088 CH) saw 25 block trades worth 80.11mn at 40.42yuan per share, 15.21pct discount from last closing.
-Mindray Bio-Medical (300760 CH) saw 28 block trades worth 881.02mn at 213.47yuan per share, 3.06pct discount from last closing.
-Jiuzhitang (000989 CH) saw 2 block trades worth 95.60mn at 9.56yuan per share, 4.02pct discount from last closing.

Disclaimer

We, Orient Futures International (Singapore) Pte. Ltd. (“OFIS”) (UEN No. 201831776Z), hold a capital markets services licence (CMS100869) from the Monetary Authority of Singapore for dealing in capital market products such as futures/derivatives contracts, and spot foreign exchange contracts for the purposes of leveraged foreign exchange trading, and is an Exempt Financial Adviser. For more information about OFIS, please check the MAS Financial Institutions Directory by clicking here.

All content, materials, information, data, statistics, features, research, documents or reports available on our website (including this article) which are financial in nature (the “Content”) are governed by our Terms of Use. By accessing, using or downloading any Content, you are deemed to have consented and agreed to the Terms of Use.

We distribute information/research (which may be prepared by us directly or produced by our foreign affiliated companies within the Orient Group of companies) pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. The information/research herein is prepared and distributed in Singapore and is intended for our clients who are Accredited Investors, Expert Investors or Institutional Investors only. If you are not an Accredited Investor, Expert Investor or Institutional Investor, you hereby acknowledge and agree that you are not the intended audience of all Content available on our website, and you undertake to immediately cease your access to any Content available on our website.

You agree to access and accept all Content available on our website on an “as-is” and “as available” basis. You agree that OFIS shall not have any responsibility or liability arising out of or in connection with, and you agree to waive the right to bring any claims or raise any complaints against OFIS in respect of any Content available on our website. OFIS shall also not be liable for any damage, loss or liability of any kind (whether actual, anticipated, consequential, special, economic or otherwise) caused as a result (direct or indirect) of the use of, or inability to access or use, the website, including but not limited to any damage, loss or liability suffered as a result of your reliance on the Content or our website.

OFIS does not make any representations, and hereby disclaim all warranties, express or implied, statutory or otherwise to the extent permitted by law, in respect of our website and all Content therein. To the fullest extent permissible, OFIS does not warrant and hereby disclaims any warranty as to the accuracy, correctness, completeness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the Content.

All Content available on our website are general in nature and have been prepared without any consideration of your investment objectives, financial situations or needs. You should consider the appropriateness of any Content available on our website having regard to your personal circumstances before making any investment decisions. You should take into account your investment objectives and financial situation and seek advice from an independent financial advisor under a separate engagement if necessary.

Subscribe to our weekly newsletter to get the latest market news